Cost of anxiety disorders in Japan in 2008

A prevalence-based approach

Mitsuhiro Sado, Sayuri Takechi, Ataru Inagaki, Daisuke Fujisawa, Akihiro Koreki, Masaru Mimura, Kimio Yoshimura

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: The societal burden caused by anxiety disorders has likely been underestimated, while those for schizophrenia and depression have received more attention. Anxiety disorders represent a significant illness category that occurs at a high prevalence and poses a considerable burden. However, the cost of anxiety disorders in Japan has not yet been well researched. The goal of the present study was to estimate the total cost of anxiety disorders in Japan and to clarify the characteristics of this burden.Method: A prevalence-based approach was adopted to measure the total cost of anxiety disorders. Anxiety disorders were defined as diagnosis code F40.0-F41.9 according to the International Statistical Classification of Diseases and Related Health Problems, 10th Revision. The cost was comprised of the following components: medical treatment costs and social service costs as direct costs, and morbidity and mortality costs as indirect costs. Data were collected from publicly available statistics. Results: The total cost of anxiety disorders in Japan in 2008 was JPY 2.4 trillion (US$ 20.5 billion at the current exchange rate of US$1 = JPY 116.8). The direct cost was JPY 50 billion. The morbidity cost was JPY 2.1 trillion, while the mortality cost was JPY 0.24 trillion. Conclusions: The social burden caused by anxiety disorders in Japan is tremendous and is similar to that of other mental disorders. Productivity loss in the workplace represents the largest portion of all the cost components. Because the medical examination rate is quite low, the improvement of healthcare access might contribute to cost mitigation.

Original languageEnglish
Article number338
JournalBMC Psychiatry
Volume13
DOIs
Publication statusPublished - 2013 Dec 18

Fingerprint

Anxiety Disorders
Japan
Costs and Cost Analysis
Morbidity
Mortality
International Classification of Diseases
Social Work
Mental Disorders
Workplace
Health Care Costs
Schizophrenia

Keywords

  • Anxiety disorders
  • Cost analysis
  • Cost of illness
  • Societal burden
  • Societal costs

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Cost of anxiety disorders in Japan in 2008 : A prevalence-based approach. / Sado, Mitsuhiro; Takechi, Sayuri; Inagaki, Ataru; Fujisawa, Daisuke; Koreki, Akihiro; Mimura, Masaru; Yoshimura, Kimio.

In: BMC Psychiatry, Vol. 13, 338, 18.12.2013.

Research output: Contribution to journalArticle

@article{6de9544434b942e5bc2e903b484ae00f,
title = "Cost of anxiety disorders in Japan in 2008: A prevalence-based approach",
abstract = "Background: The societal burden caused by anxiety disorders has likely been underestimated, while those for schizophrenia and depression have received more attention. Anxiety disorders represent a significant illness category that occurs at a high prevalence and poses a considerable burden. However, the cost of anxiety disorders in Japan has not yet been well researched. The goal of the present study was to estimate the total cost of anxiety disorders in Japan and to clarify the characteristics of this burden.Method: A prevalence-based approach was adopted to measure the total cost of anxiety disorders. Anxiety disorders were defined as diagnosis code F40.0-F41.9 according to the International Statistical Classification of Diseases and Related Health Problems, 10th Revision. The cost was comprised of the following components: medical treatment costs and social service costs as direct costs, and morbidity and mortality costs as indirect costs. Data were collected from publicly available statistics. Results: The total cost of anxiety disorders in Japan in 2008 was JPY 2.4 trillion (US$ 20.5 billion at the current exchange rate of US$1 = JPY 116.8). The direct cost was JPY 50 billion. The morbidity cost was JPY 2.1 trillion, while the mortality cost was JPY 0.24 trillion. Conclusions: The social burden caused by anxiety disorders in Japan is tremendous and is similar to that of other mental disorders. Productivity loss in the workplace represents the largest portion of all the cost components. Because the medical examination rate is quite low, the improvement of healthcare access might contribute to cost mitigation.",
keywords = "Anxiety disorders, Cost analysis, Cost of illness, Societal burden, Societal costs",
author = "Mitsuhiro Sado and Sayuri Takechi and Ataru Inagaki and Daisuke Fujisawa and Akihiro Koreki and Masaru Mimura and Kimio Yoshimura",
year = "2013",
month = "12",
day = "18",
doi = "10.1186/1471-244X-13-338",
language = "English",
volume = "13",
journal = "BMC Psychiatry",
issn = "1471-244X",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Cost of anxiety disorders in Japan in 2008

T2 - A prevalence-based approach

AU - Sado, Mitsuhiro

AU - Takechi, Sayuri

AU - Inagaki, Ataru

AU - Fujisawa, Daisuke

AU - Koreki, Akihiro

AU - Mimura, Masaru

AU - Yoshimura, Kimio

PY - 2013/12/18

Y1 - 2013/12/18

N2 - Background: The societal burden caused by anxiety disorders has likely been underestimated, while those for schizophrenia and depression have received more attention. Anxiety disorders represent a significant illness category that occurs at a high prevalence and poses a considerable burden. However, the cost of anxiety disorders in Japan has not yet been well researched. The goal of the present study was to estimate the total cost of anxiety disorders in Japan and to clarify the characteristics of this burden.Method: A prevalence-based approach was adopted to measure the total cost of anxiety disorders. Anxiety disorders were defined as diagnosis code F40.0-F41.9 according to the International Statistical Classification of Diseases and Related Health Problems, 10th Revision. The cost was comprised of the following components: medical treatment costs and social service costs as direct costs, and morbidity and mortality costs as indirect costs. Data were collected from publicly available statistics. Results: The total cost of anxiety disorders in Japan in 2008 was JPY 2.4 trillion (US$ 20.5 billion at the current exchange rate of US$1 = JPY 116.8). The direct cost was JPY 50 billion. The morbidity cost was JPY 2.1 trillion, while the mortality cost was JPY 0.24 trillion. Conclusions: The social burden caused by anxiety disorders in Japan is tremendous and is similar to that of other mental disorders. Productivity loss in the workplace represents the largest portion of all the cost components. Because the medical examination rate is quite low, the improvement of healthcare access might contribute to cost mitigation.

AB - Background: The societal burden caused by anxiety disorders has likely been underestimated, while those for schizophrenia and depression have received more attention. Anxiety disorders represent a significant illness category that occurs at a high prevalence and poses a considerable burden. However, the cost of anxiety disorders in Japan has not yet been well researched. The goal of the present study was to estimate the total cost of anxiety disorders in Japan and to clarify the characteristics of this burden.Method: A prevalence-based approach was adopted to measure the total cost of anxiety disorders. Anxiety disorders were defined as diagnosis code F40.0-F41.9 according to the International Statistical Classification of Diseases and Related Health Problems, 10th Revision. The cost was comprised of the following components: medical treatment costs and social service costs as direct costs, and morbidity and mortality costs as indirect costs. Data were collected from publicly available statistics. Results: The total cost of anxiety disorders in Japan in 2008 was JPY 2.4 trillion (US$ 20.5 billion at the current exchange rate of US$1 = JPY 116.8). The direct cost was JPY 50 billion. The morbidity cost was JPY 2.1 trillion, while the mortality cost was JPY 0.24 trillion. Conclusions: The social burden caused by anxiety disorders in Japan is tremendous and is similar to that of other mental disorders. Productivity loss in the workplace represents the largest portion of all the cost components. Because the medical examination rate is quite low, the improvement of healthcare access might contribute to cost mitigation.

KW - Anxiety disorders

KW - Cost analysis

KW - Cost of illness

KW - Societal burden

KW - Societal costs

UR - http://www.scopus.com/inward/record.url?scp=84890391163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890391163&partnerID=8YFLogxK

U2 - 10.1186/1471-244X-13-338

DO - 10.1186/1471-244X-13-338

M3 - Article

VL - 13

JO - BMC Psychiatry

JF - BMC Psychiatry

SN - 1471-244X

M1 - 338

ER -